(1888PressRelease)
April 18, 2006 - April 16, 2006 - Yesterday, respected Producer and Promoter, Don Grenough, met with Imperiali Organization Founder, Daniel Imperato, in Hollywood regarding the upcoming film, The Red Worm.
This marks a significant sign of huge potential collaboration between one of Hollywood’s most famous promoters and one of the more notable films of this year, The Red Worm.
Discussions between Grenough, and i1films West Coast Representative, Julio Herzer, have come to a conclusion with Grenough potentially putting his promotions ability behind the Imperiali Organization, i1films, and The Red Worm.
Grenough over the past 25 years has successfully produced or promoted over 1000 concerts for entertainment icons such as Prince, Tom Jones, Sting, Julio Iglesias, Lionel Richie, Billy Idol, Diana Ross, The Jacksons, Paul Simon, Rick James, Mariah Carey, Gloria Estefan, and Andrea Bocellli – to name a few.
In addition, Grenough was a co-founder of Herbalife and played an instrumental role in establishing Herbalife as a multi-billion dollar giant.
Imperato stated that an arrangement is in process to associate the Imperiali Organization with Grenough and that collaborations may be forthcoming.
About Imperiali Organization Imperiali Organization (www.imperiali.org) is global development company, with diversified assets and holdings, connecting the leaders of tomorrow today. Currently the organization has taken interest in both in owned and operated businesses in the areas of internet search, public relations, merchandising, publishing, film, and sports as well as other non-affiliated companies. The Imperiali Organization is currently the official communications provider for Imperato For President 2008, www.daniel2008.com .
Safe Harbor Statements under the Private Securities Litigation Reform Act of 1965: Those statements contained herein which are not historical are forward-looking statements, and as such, are subject to risks and uncertainties that could cause actual operating results to materially differ from those contained in the forward-looking statements. Such statements include, but are not limited to, certain delays that are beyond the Company’s control, with respect to market acceptance of new technologies, or product delays in the testing and evaluation of products, and other risks, as detailed in the Company’s periodic filings with the Securities and Exchange Commission.
For Press Inquires Contact:
i1connect
561-305-0519
info ( @ ) i1connect dot com
www.i1connect.com
